Search

Your search keyword '"Marc Noguera-Julian"' showing total 60 results

Search Constraints

Start Over You searched for: Author "Marc Noguera-Julian" Remove constraint Author: "Marc Noguera-Julian" Language english Remove constraint Language: english
60 results on '"Marc Noguera-Julian"'

Search Results

2. Gut resistome linked to sexual preference and HIV infection

3. Vaccination with an HIV T-cell immunogen induces alterations in the mouse gut microbiota

4. Monitoring SARS-CoV-2 variant transitions using differences in diagnostic cycle threshold values of target genes

5. Effectiveness and safety of integrase strand transfer inhibitors in Spain: a prospective real-world study

6. Impact of hybrid immunity booster vaccination and Omicron breakthrough infection on SARS-CoV-2 VOCs cross-neutralization

7. Gut microbiome signatures linked to HIV-1 reservoir size and viremia control

8. Vaccination with an HIV T-Cell Immunogen (HTI) Using DNA Primes Followed by a ChAdOx1-MVA Boost Is Immunogenic in Gut Microbiota-Depleted Mice despite Low IL-22 Serum Levels

9. Probiotic effects on immunity and microbiome in HIV-1 discordant patients

11. Performance of SARS-CoV-2 Antigen-Detecting Rapid Diagnostic Tests for Omicron and Other Variants of Concern

12. Pre-Transplant Prediction of Acute Graft-versus-Host Disease Using the Gut Microbiome

13. Evolution of the gut microbiome following acute HIV-1 infection

14. Identification of Plitidepsin as Potent Inhibitor of SARS-CoV-2-Induced Cytopathic Effect After a Drug Repurposing Screen

15. Yaws re-emergence and bacterial drug resistance selection after mass administration of azithromycin: a genomic epidemiology investigation

16. Richer gut microbiota with distinct metabolic profile in HIV infected Elite Controllers

17. Gut Microbiota Linked to Sexual Preference and HIV Infection

18. SARS-CoV-2 Consensus-Sequence and Matching Overlapping Peptides Design for COVID19 Immune Studies and Vaccine Development

19. Dry Panels Supporting External Quality Assessment Programs for Next Generation Sequencing-Based HIV Drug Resistance Testing

20. Multi-Laboratory Comparison of Next-Generation to Sanger-Based Sequencing for HIV-1 Drug Resistance Genotyping

21. Are We Ready for NGS HIV Drug Resistance Testing? The Second 'Winnipeg Consensus' Symposium

22. Guiding the humoral response against HIV-1 toward a MPER adjacent region by immunization with a VLP-formulated antibody-selected envelope variant.

23. Benzyl-2-Acetamido-2-Deoxy-α-d-Galactopyranoside Increases Human Immunodeficiency Virus Replication and Viral Outgrowth Efficacy In Vitro

24. HIV drug resistance patterns in pregnant women using next generation sequence in Mozambique.

25. Virological and immunological outcome of treatment interruption in HIV-1-infected subjects vaccinated with MVA-B.

26. Plasma HIV-1 Tropism and the Risk of Short-Term Clinical Progression to AIDS or Death.

27. Mutations Related to Antiretroviral Resistance Identified by Ultra-Deep Sequencing in HIV-1 Infected Children under Structured Interruptions of HAART.

28. Decreased phenotypic susceptibility to etravirine in patients with predicted genotypic sensitivity.

29. HIV-1 tropism testing in subjects achieving undetectable HIV-1 RNA: diagnostic accuracy, viral evolution and compartmentalization.

30. Author Correction to: SARS-CoV-2 interaction with Siglec-1 mediates trans-infection by dendritic cells

31. Clinical course impacts early kinetics,magnitude, and amplitude of SARS-CoV-2 neutralizing antibodies beyond 1 year after infection

32. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Infection and Humoral Responses Against Different Variants of Concern in Domestic Pet Animals and Stray Cats from North-Eastern Spain

33. Performance of 16S Metagenomic Profiling in Formalin-Fixed Paraffin-Embedded versus Fresh-Frozen Colorectal Cancer Tissues

34. Monitoring Natural SARS-CoV-2 Infection in Lions (Panthera leo) at the Barcelona Zoo: Viral Dynamics and Host Responses

35. Array-based Dynamic Allele Specific Hybridization (Array-DASH): optimization-free microarray processing for multiple simultaneous genomic assays

36. SARS-CoV-2 interaction with Siglec-1 mediates trans-infection by dendritic cells

37. Protection against reinfection with D614- or G614-SARS-CoV-2 isolates in golden Syrian hamster

38. Dry Panels Supporting External Quality Assessment Programs for Next Generation Sequencing-Based HIV Drug Resistance Testing

39. Detection of SARS-CoV-2 in a cat owned by a COVID-19−affected patient in Spain

40. Associations of the gut microbiome and clinical factors with acute GVHD in allogeneic HSCT recipients

41. Are We Ready for NGS HIV Drug Resistance Testing? The Second 'Winnipeg Consensus' Symposium

42. Host genetic associations with the gut microbiota in HIV-1-infected subjects: a pilot exploratory study

43. Balances: a New Perspective for Microbiome Analysis

44. Primary resistance to integrase strand transfer inhibitors in patients infected with diverse HIV-1 subtypes in sub-Saharan Africa

45. Clinically relevant thresholds for ultrasensitive HIV drug resistance testing: a multi-country nested case-control study

46. Virological and immunological outcome of treatment interruption in HIV-1-infected subjects vaccinated with MVA-B

47. Next-Generation Human Immunodeficiency Virus Sequencing for Patient Management and Drug Resistance Surveillance

48. Mutations Related to Antiretroviral Resistance Identified by Ultra-Deep Sequencing in HIV-1 Infected Children under Structured Interruptions of HAART

49. Decreased phenotypic susceptibility to etravirine in patients with predicted genotypic sensitivity

50. HIV-1 Tropism Testing in Subjects Achieving Undetectable HIV-1 RNA: Diagnostic Accuracy, Viral Evolution and Compartmentalization

Catalog

Books, media, physical & digital resources